# Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population

> **NCT05926258** · PHASE3 · COMPLETED · sponsor: **Sintetica SA** · enrollment: 74 (actual)

## Conditions studied

- Local Anesthetic

## Interventions

- **DRUG:** Chloroprocaine 3% eye gel
- **DRUG:** Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops

## Key facts

- **NCT ID:** NCT05926258
- **Lead sponsor:** Sintetica SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-23
- **Primary completion:** 2025-03-13
- **Final completion:** 2025-03-13
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05926258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05926258, "Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05926258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*